Bridge Creek Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-30,425
| Closed | -$281K | – | 92 |
|
|
2019
Q2 | $281K | Buy |
30,425
+2,600
| +9% | +$24K | 0.14% | 83 |
|
|
2019
Q1 | $436K | Sell |
27,825
-675
| -2% | -$10.6K | 0.22% | 72 |
|
|
2018
Q4 | $439K | Sell |
28,500
-100
| -0.3% | -$1.54K | 0.25% | 70 |
|
|
2018
Q3 | $616K | Sell |
28,600
-107
| -0.4% | -$2.31K | 0.31% | 64 |
|
|
2018
Q2 | $698K | Sell |
28,707
-245
| -0.8% | -$5.96K | 0.37% | 63 |
|
|
2018
Q1 | $495K | Buy |
28,952
+125
| +0.4% | +$2.14K | 0.26% | 69 |
|
|
2017
Q4 | $546K | Sell |
28,827
-10,870
| -27% | -$206K | 0.27% | 65 |
|
|
2017
Q3 | $699K | Buy |
39,697
+8,255
| +26% | +$145K | 0.37% | 63 |
|
|
2017
Q2 | $1.05M | Sell |
31,442
-19
| -0.1% | -$631 | 0.57% | 58 |
|
|
2017
Q1 | $1.01M | Buy |
31,461
+5,750
| +22% | +$185K | 0.56% | 58 |
|
|
2016
Q4 | $932K | Buy |
25,711
+442
| +2% | +$16K | 0.53% | 58 |
|
|
2016
Q3 | $1.16M | Buy |
25,269
+4,665
| +23% | +$215K | 0.67% | 55 |
|
|
2016
Q2 | $1.04M | Buy |
20,604
+1,765
| +9% | +$88.7K | 0.61% | 56 |
|
|
2016
Q1 | $1.01M | Hold |
18,839
| – | – | 0.58% | 58 |
|
|
2015
Q4 | $1.24M | Buy |
+18,839
| New | +$1.24M | 0.75% | 54 |
|